pI: 10.9517 |
Length (AA): 256 |
MW (Da): 28287 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
7 | 243 | 2otd (A) | 5 | 240 | 21.00 | 0.00000000066 | 0.98 | 1.21508 | -0.04 |
10 | 251 | 3i10 (A) | 42 | 298 | 21.00 | 0 | 1 | 1.14841 | 0.01 |
12 | 155 | 5vug (A) | 11 | 172 | 29.00 | 0.66 | 1 | 0.8568 | -0.71 |
171 | 247 | 3rlg (A) | 187 | 261 | 35.00 | 0.047 | 0.55 | 0.596081 | 0.13 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_127726)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G71340 | glycerophosphodiester phosphodiesterase |
Brugia malayi | Bm1_01870 | Glycerophosphoryl diester phosphodiesterase family protein |
Caenorhabditis elegans | CELE_T12B3.3 | Protein T12B3.3 |
Dictyostelium discoideum | DDB_G0271374 | hypothetical protein |
Drosophila melanogaster | Dmel_CG14883 | CG14883 gene product from transcript CG14883-RA |
Escherichia coli | b3449 | glycerophosphodiester phosphodiesterase, cytosolic |
Entamoeba histolytica | EHI_113970 | glycerophosphoryl diester phosphodiesterase, putative |
Homo sapiens | ENSG00000006007 | glycerophosphodiester phosphodiesterase 1 |
Leishmania braziliensis | LbrM.24.2240 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_242250.1 | Glycerophosphoryl diester phosphodiesterase family, putative |
Leishmania infantum | LinJ.24.2250 | hypothetical protein, conserved |
Leishmania major | LmjF.24.2160 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.24.2160 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_12305 | hypothetical protein |
Mycobacterium leprae | ML0074 | Probable glycerophosphoryl diester phosphodiesterase GlpQ1 (glycerophosphodiester phosphodiesterase) |
Mus musculus | ENSMUSG00000033917 | glycerophosphodiester phosphodiesterase 1 |
Mycobacterium tuberculosis | Rv3842c | Probable glycerophosphoryl diester phosphodiesterase GlpQ1 (glycerophosphodiester phosphodiesterase) |
Mycobacterium tuberculosis | Rv0317c | Possible glycerophosphoryl diester phosphodiesterase GlpQ2 (glycerophosphodiester phosphodiesterase) |
Mycobacterium ulcerans | MUL_5015 | glycerophosphoryl diester phosphodiesterase |
Mycobacterium ulcerans | MUL_1157 | glycerophosphoryl diester phosphodiesterase |
Oryza sativa | 4350150 | Os11g0236000 |
Onchocerca volvulus | OVOC5492 | Glycerophosphodiester phosphodiesterase 1 homolog |
Schmidtea mediterranea | mk4.035731.01 | |
Trypanosoma brucei gambiense | Tbg972.8.6110 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.8.6080 | Glycerophosphoryl diester phosphodiesterase family, putative |
Trypanosoma cruzi | TcCLB.511901.30 | Glycerophosphoryl diester phosphodiesterase family, putative |
Trypanosoma cruzi | TcCLB.511071.100 | Present in the outer mitochondrial membrane proteome 42 |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
mtu3909 | Mycobacterium tuberculosis | non-essential | nmpdr |
Tb927.8.6080 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.8.6080 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.8.6080 | Trypanosoma brucei | significant gain of fitness in procyclic forms | alsford |
Tb927.8.6080 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
b3449 | Escherichia coli | non-essential | goodall |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.